Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 9/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29545012 | 0.92 | EGFR (0.41) | EGFR | |
| SCHEMBL29544682 | 0.89 | EGFR (0.42) | EGFR | |
| SCHEMBL29545365 | 0.84 | TYK2 (0.33) | EGFR | |
| SCHEMBL29544736 | 0.79 | EGFR (0.40) | EGFR | |
| SCHEMBL29544418 | 0.79 | EGFR (0.39) | EGFR | |
| SCHEMBL29545140 | 0.78 | EGFR (0.42) | EGFR | |
| SCHEMBL29544488 | 0.76 | EGFR (0.37) | EGFR | |
| SCHEMBL29544468 | 0.76 | EGFR (0.41) | EGFR | |
| SCHEMBL29544852 | 0.75 | EGFR (0.49) | EGFR | |
| SCHEMBL29544860 | 0.75 | EGFR (0.49) | EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022072634-A1 | BICYCLIC COMPOUNDS FOR USE IN THE TREATMENT CANCER | SCORPION THERAPEUTICS, INC. (US) | 2022-04-07 | — | — | WO | disclosed |